pristanic acid has been researched along with Polyneuropathies in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beaulieu, CL; Boycott, KM; Bulman, DE; Ferdinandusse, S; Geraghty, MT; Gottlieb, CC; Lawrence, SE; Mackenzie, A; Majewski, J; McMillan, HJ; Mooyer, PA; Schwartzentruber, J; Wanders, RJ; Worthylake, T | 1 |
Denis, S; Dillmann, U; Duran, M; Ferdinandusse, S; Haas, D; Kostopoulos, P; Marziniak, M; Overmars, H; Reith, W; Rusch, H; Wanders, RJ | 1 |
2 other study(ies) available for pristanic acid and Polyneuropathies
Article | Year |
---|---|
Specific combination of compound heterozygous mutations in 17β-hydroxysteroid dehydrogenase type 4 (HSD17B4) defines a new subtype of D-bifunctional protein deficiency.
Topics: 17-Hydroxysteroid Dehydrogenases; Cerebellar Ataxia; Fatty Acids; Hearing Loss, Sensorineural; Heterozygote; Hydro-Lyases; Mutation; Peroxisomal Multifunctional Protein-2; Phytanic Acid; Polyneuropathies; Retinitis Pigmentosa | 2012 |
Mutations in the gene encoding peroxisomal sterol carrier protein X (SCPx) cause leukencephalopathy with dystonia and motor neuropathy.
Topics: Adult; Carrier Proteins; Codon, Nonsense; Dementia, Vascular; Dystonia; Fatty Acids; Frameshift Mutation; Glucuronides; Humans; Magnetic Resonance Imaging; Male; Polyneuropathies; Pons; Syndrome; Thalamus; Torticollis | 2006 |